CurrentUnitedHealthcarePolicy DCP016.17

General Anesthesia and Conscious Sedation Services

This UnitedHealthcare dental clinical policy (DCP016.17) governs the clinical indications, contraindications, definitions, applicable CDT procedure codes, and guidance for provision of nitrous oxide, non-intravenous conscious sedation, intravenous moderate/conscious sedation, deep sedation, and general anesthesia in dental office settings. It applies to services provided in a dental office and defers to member-specific benefit plan documents and applicable mandates for coverage determinations.

Policy Summary

PayerUnitedHealthcare

PolicyGeneral Anesthesia and Conscious Sedation Services

Policy CodePolicy DCP016.17

Change TypeDefinitions addedsupporting information and references updated

Effective DateSep 1, 2025

Next Review Date

Key ActionBefore determining coverage, reference the member-specific benefit plan document and applicable federal/state mandates; benefits may differ and govern in the event of a conflict.

SourceLink

POLICY UPDATE CHANGES

Added definition of 'Nitrous Oxide'.

Updated Supporting Information, Clinical Evidence and References sections to reflect the most current information.

10Referenced CDT codes

6Absolute contraindications listed

7Indications/considerations listed

Coverage Summary

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Overview: This guidance addresses the administration of dental anesthesia and sedation services in dental office settings, including nitrous oxide, non-intravenous conscious sedation, intravenous moderate/conscious sedation, and deep sedation/general anesthesia. It summarizes clinical indications, contraindications, definitions, and referenced CDT procedure codes and emphasizes safe practice in the office setting. Actual benefit coverage and payment are determined by the member-specific benefit plan document and any applicable federal or state mandates, which govern in the event of conflict.

Policy metadata

policy_numberDCP016.17

statusCURRENT

dates.effective2025-09-01

dates.last_review2025-09-01

subjectDental anesthesia and sedation services (nitrous oxide, conscious sedation, deep sedation/general anesthesia)

Medical-Necessity Criteria

Nitrous Oxide - Indications and Contraindications

Nitrous Oxide may be indicated when ANY of the following are present; contraindications list conditions where use is inadvisable or absolutely contraindicated.

ANY of the following

Extensive and/or complex procedures (e.g., serial extractions, periodontal surgeries)
Individuals with physical, cognitive, or developmental disabilities
Ineffective Local Anesthesia
Management of a severe gag reflex
Management of fear and anxiety

Relative Contraindications (may be contraindicated)

Claustrophobia
Pregnancy
Severe underlying medical conditions (e.g., critical illnesses, cardiac disease, pulmonary hypertension)
Significant personality and behavioral disorders
Upper respiratory tract infections or other respiratory conditions

Absolute Contraindications

Methylenetetrahydrofolate reductase (MTHFR) deficiency
Pulmonary hypertension
Severe chronic obstructive pulmonary disease (COPD)
Treatment with bleomycin sulfate
Vitamin B12 deficiency
Within three months of vitreoretinal surgery

Intravenous Moderate/Conscious Sedation and Deep Sedation/General Anesthesia - Indications and Considerations

IV moderate/conscious sedation and deep sedation/general anesthesia may be indicated when ANY of the following are met; contraindications and risk factors noted elsewhere may preclude use.

ANY of the following

Allergy or sensitivity to local anesthetic agents
Extensive and/or complex procedures (e.g., serial extractions, periodontal surgeries)
Anxiety and fear when other techniques have proven inadequate
Behavioral management when other techniques have proven inadequate
Individuals that are medically compromised or those with special needs

Non-Intravenous Conscious Sedation - Indications

Non-intravenous sedation may be indicated when ANY of the following are present:

ANY of the following

Individuals with physical, cognitive, or developmental disabilities
Mild to moderate apprehension and anxiety

Relevant Codes

Referenced CDT procedure codes (for anesthesia/sedation services) - informational listmixed

D9210	Local anesthesia not in conjunction with operative or surgical procedures
D9211	Regional block anesthesia
D9212	Trigeminal division block anesthesia
D9215	Local anesthesia in conjunction with operative or surgical procedures
D9219	Evaluation for moderate sedation, deep sedation or general anesthesia
D9222	Deep sedation/general anesthesia - first 15 minutes
D9223	Deep sedation/general anesthesia - each subsequent 15 minute increment
D9230	Inhalation of nitrous oxide/analgesia, anxiolysis
D9239	Intravenous moderate (conscious) sedation/anesthesia - first 15 minutes
D9243	Intravenous moderate (conscious) sedation/analgesia - each subsequent 15 minute increment

1–10 of 11

1/2

Provider Actions & Authorization

Documentation Required

Reference member-specific benefit plan for coverage

Before making coverage decisions, check the member-specific benefit plan document and any applicable federal or state mandates, since benefits may differ and govern in the event of a conflict.

Documentation Required

Comply with ADA/state training and monitoring requirements

Comply with ADA and state educational/training requirements and document patient history, evaluation, monitoring (including consciousness, oxygenation, ventilation, and circulation), recovery/discharge, and emergency management as applicable.

Documentation Required

Ensure appropriate facility resources and personnel

For deep sedation, general anesthesia, and higher-risk patients ensure availability of qualified anesthesia providers, personnel trained in advanced resuscitation (e.g., ACLS/PALS), reliable emergency equipment (oxygen, suction, resuscitation drugs/equipment), and a protocol for accessing emergency medical services.

Prior Authorization

Coverage determinations require benefit verification

Obtain prior authorization per the member's specific benefit plan when the plan requires it; this policy is informational and coverage requires verification against the member-specific plan and applicable mandates.

Denial Risk

Potential denial if contraindications present

Claims may be denied if documented absolute contraindications to nitrous oxide or sedation/anesthesia are present.

Methylenetetrahydrofolate reductase (MTHFR) deficiency
Pulmonary hypertension
Severe chronic obstructive pulmonary disease (COPD)
Treatment with bleomycin sulfate
Vitamin B12 deficiency
Within three months of vitreoretinal surgery

Definitions and Evidence

Purpose: This policy provides informational guidance to promote safe delivery of dental sedation and anesthesia by emphasizing provider training, patient evaluation, monitoring, documentation, appropriate facility resources, and emergency preparedness in alignment with ADA, ASA, and AAPD guidance. It is informational only and defers to the member-specific benefit plan and applicable mandates for coverage determinations.

Definitions

Deep SedationA drug-induced depression of consciousness during which patients cannot be easily aroused but respond purposefully following repeated or painful stimulation; ventilatory function may be impaired; patients may require airway assistance.

General AnesthesiaA drug-induced loss of consciousness during which patients are not arousable, even by painful stimulation; ventilatory function often impaired and positive pressure ventilation may be required.

Local AnesthesiaElimination of sensation in one part of the body by topical application or regional injection of a drug.

Moderate SedationA drug-induced depression of consciousness during which patients respond purposefully to verbal commands; no interventions are required to maintain airway; spontaneous ventilation is adequate.

Nitrous OxideA colorless, odorless to sweet-smelling inorganic gas which, when combined with oxygen, can be a safe and effective means of managing pain and anxiety.

Non-Intravenous SedationSedation medications delivered through oral, intranasal, or transmucosal routes.

Evidence: Guideline references include ADA, AAPD, ASA, and AAO practice guidance and multiple peer-reviewed sources and textbooks; references and supporting information were reviewed and cited (accessed June 23, 2025) to inform definitions, indications, contraindications, monitoring, and safety recommendations.

Policy Summary

PayerUnitedHealthcare

PolicyGeneral Anesthesia and Conscious Sedation Services

Policy CodePolicy DCP016.17

Change TypeDefinitions addedsupporting information and references updated

Effective DateSep 1, 2025

Next Review Date

Key ActionBefore determining coverage, reference the member-specific benefit plan document and applicable federal/state mandates; benefits may differ and govern in the event of a conflict.

SourceLink

On This Page

OpenPayer

General Anesthesia and Conscious Sedation Services

Coverage Summary

Medical-Necessity Criteria

Relevant Codes

Provider Actions & Authorization

Definitions and Evidence

Revision History